What Is BPC-157?
BPC-157 is a synthetic peptide made up of 15 amino acids. Its name comes from “Body Protection Compound,” and it was developed from research involving compounds found in gastric—or stomach—proteins.
It’s become particularly well known in the peptide world for claims surrounding injury recovery, tendons, ligaments, muscles and gut health.
There is legitimate research behind many of those areas.
However, there’s an important catch: the overwhelming majority of BPC-157 research has been conducted in animals rather than people. A 2026 review described more than three decades of preclinical research but noted that pharmaceutical development remains limited and that no Phase II clinical trial has been completed.
Why Are Researchers Interested in It?
BPC-157 has produced interesting results across several different areas of laboratory and animal research.
Two of the biggest are:
Tissue & injury repair — Researchers have investigated BPC-157 in models involving damaged tendons, ligaments, skeletal muscle and other soft tissues.
Gastrointestinal protection — Because of BPC-157’s origins in gastric research, scientists have also investigated stomach ulcers, intestinal injury and other forms of gastrointestinal damage.
For example, rat studies have found accelerated healing in experimentally induced gastric ulcers.
Reviews of musculoskeletal research have also reported encouraging results involving tendon, ligament and skeletal-muscle healing—but emphasize that these findings still need confirmation in humans.
How Might BPC-157 Work?
Researchers don’t yet have one definitive mechanism explaining all of BPC-157’s reported effects.
Several biological systems have been investigated.
Blood Vessel Formation
One important area is angiogenesis, which is the process of forming new blood vessels.
Blood supply matters during healing because injured tissue needs oxygen and nutrients.
BPC-157 has demonstrated effects involving angiogenesis and blood-vessel biology in preclinical experiments.
Nitric Oxide
Researchers have also studied BPC-157’s interaction with the body’s nitric oxide system.
Nitric oxide participates in blood-vessel function, circulation and numerous cellular signaling processes. BPC-157’s interaction with this system has been repeatedly investigated in animal research.
Cellular & Tissue Repair
Other research has examined processes involving cell migration, blood-vessel integrity and tissue remodeling.
In beginner terms:
BPC-157 appears to interact with several of the biological systems the body uses when responding to injury.
But researchers still don’t know whether these effects translate into meaningful healing benefits in humans.
What About Tendons, Ligaments & Muscles?
This is probably why many people first hear about BPC-157.
Animal experiments have investigated injuries involving:
Tendons → ligaments → skeletal muscle → other connective and soft tissues.
A review of the musculoskeletal literature found consistently encouraging healing results across the animal studies it examined.
But the authors also highlighted the big limitation:
most of the research involved small rodents, and effectiveness has not been confirmed in humans.
So there’s a real scientific reason BPC-157 became associated with injury recovery.
There just isn’t enough human evidence yet to call it a proven injury-recovery treatment.
What About Gut Health?
The gastrointestinal research behind BPC-157 is substantial—but again, much of it is preclinical.
Researchers have studied BPC-157 in animal models involving:
- Stomach ulcers
- Intestinal damage
- Esophageal injury
- Gastrointestinal inflammation
- Surgical intestinal connections
- Fistulas
- Short-bowel models
Rat studies have repeatedly reported protective and healing effects in damaged gastrointestinal tissue.
That’s where online claims like “BPC heals the gut” originate.
But that’s much stronger language than the human evidence currently allows.
What About IBD & Ulcerative Colitis?
This part is especially worth explaining because older publications sometimes state that BPC-157 was tested in clinical trials involving inflammatory bowel disease.
FDA performed a much more recent review.
In July 2026, FDA concluded that there was a lack of evidence supporting BPC-157 as a treatment for ulcerative colitis. The agency identified a single small trial, but said interpretation was limited because only a meeting abstract provided details and the study was exploratory.
So it would be misleading to describe BPC-157 as having established human evidence for IBD.
Evidence Snapshot
Laboratory Research: Yes
Animal Research: Extensive
Human Research: Extremely limited
Musculoskeletal Human Evidence: Not established
Human Gut/IBD Evidence: Very limited
FDA Approved: No
Overall Evidence: Promising preclinical research, insufficient clinical evidence
This is probably the single most important thing for beginners to understand about BPC-157.
There’s a big gap between how established BPC-157 sounds online and how much human clinical evidence actually exists.
What Do We Know?
BPC-157 isn’t simply something invented by peptide sellers.
There is a genuine scientific literature behind it spanning decades.
Animal studies have reported interesting effects involving:
tissue healing, gastrointestinal protection, tendon and ligament recovery, muscle injury, angiogenesis, vascular biology and other injury-response pathways.
Those findings justify continued research.
They do not establish the same effects in humans.
What Don’t We Know?
This list is considerably longer than social media sometimes makes it sound.
We don’t have strong clinical evidence establishing that BPC-157:
- Heals tendon injuries in humans
- Repairs torn ligaments
- Speeds muscle recovery
- Treats chronic joint pain
- Heals ulcers in humans
- Treats Crohn’s disease
- Treats ulcerative colitis
- “Heals leaky gut”
- Treats arthritis
- Repairs nerve damage
- Reliably speeds recovery after surgery
Some of these claims have preclinical research behind them.
That’s different from having clinical proof.
What About Safety?
This is another major unknown.
The absence of large numbers of reported problems online shouldn’t be confused with established safety.
FDA states that compounded products containing BPC-157 may pose risks involving immune reactions and peptide-related impurities, and that available safety information for proposed routes of administration is limited. FDA therefore says it lacks sufficient information to determine whether BPC-157 would cause harm when administered to humans.
That doesn’t mean FDA has established that BPC-157 is dangerous.
It means we don’t have enough reliable human safety information to establish that it is safe.
Research & Regulatory Status
BPC-157 is not an FDA-approved drug.
As of 2026, there is no approved BPC-157 formulation, validated clinical dosing regimen, or completed Phase II clinical trial.
Its popularity in research-peptide markets therefore exists far ahead of its development as a conventional pharmaceutical.
Your Pep Resource Takeaway
BPC-157 is a perfect example of a compound where the hype didn’t come completely out of nowhere.
There really are decades of intriguing experiments involving healing, gastrointestinal protection, tendons, ligaments, muscles and blood-vessel biology.
But there’s also a huge missing piece:
humans.
The animal research makes BPC-157 interesting enough to study further.
It does not make BPC-157 a proven human treatment for injuries, gut problems or chronic pain.
Research Areas / Search Keywords
BPC-157, BPC 157, Body Protection Compound, healing, healing peptide, injury recovery, faster recovery research, injury healing, tissue repair, tissue healing, tissue regeneration, wound healing, wound repair, sports injuries, athletic recovery, workout recovery, exercise recovery, muscle recovery, sore muscles research, muscle injury, muscle tear research, muscle healing, tendon health, tendon injury, tendon pain research, tendon healing, tendon repair, tendonitis research, Achilles tendon research, ligament health, ligament injury, ligament tear research, ligament healing, ligament repair, joint health, joint injury, joint pain research, arthritis research, inflammation, inflammatory response, cartilage research, connective tissue, soft tissue injury, gut health, gut healing research, digestive health, digestive problems research, gastrointestinal health, GI health, stomach health, stomach lining, stomach ulcers, ulcer research, intestinal health, intestinal healing research, gut inflammation, intestinal inflammation, inflammatory bowel disease research, IBD research, Crohn’s disease research, ulcerative colitis research, leaky gut research, GERD research, acid reflux research, esophagus research, surgical recovery research, surgical healing research, angiogenesis, blood vessel formation, circulation research, vascular health, nitric oxide, nerve health research, nerve injury research, nerve repair research, neuroprotection, regenerative medicine, recovery peptides.
Educational Disclaimer: This profile is provided for educational and research-information purposes only. It is not medical advice and does not provide dosing, administration, treatment, or purchasing recommendations. BPC-157 is not FDA approved, and its safety and effectiveness in humans have not been established.